FYI - For Your Innovation20 Mar 2025

Revolutionizing Cancer Treatment: Umoja’s Vision For In Vivo Therapies

In this episode of For Your Innovation, the ARK team is joined by Umoja’s CEO, Dr. Andy Scharenberg, and CFO, Britton Russell, to discuss their journey, vision, and the innovative science reshaping cancer treatment. Dr. Scharenberg explains how Umoja’s in vivo gene delivery platform, VivoVec, represents a third-generation leap in CAR T-cell therapies—offering the potential to make cutting-edge treatments more scalable, accessible, and cost-effective. Britton Russell provides insights into how this paradigm shift is aligned with Umoja’s mission to democratize transformative medicine, enabling broader global access. Together, they explore topics ranging from the shortcomings of traditional CAR T-cell therapies, the challenges of current allogeneic solutions, and how Umoja’s platform overcomes these barriers. They also discuss the implications of in vivo therapies for oncology, autoimmune diseases, and even longevity, while touching on the role of better healthcare models and incentive structures to move the industry from "sick care" to true healthcare innovation.

Key Points From This Episode:

The limitations of existing CAR T-cell therapies and how Umoja addresses them.
How in vivo platforms reduce costs and streamline treatment timelines.
The broader applications of Umoja’s technology beyond oncology, including autoimmunity and longevity.
Why better alignment of healthcare incentives is critical for advancing patient outcomes.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(299)

Elon Musk's $1 Trillion Chip Factory | The Brainstorm 147

In this episode of The Brainstorm, Sam and Brett unpack SpaceX’s $100 billion Louisiana buildout, one of the largest infrastructure projects in history, and why the returns on Starlink, AI satellites,...

2 Sep 35min

Moderna's Cancer Vaccine May Cut Deaths In Half | The Brainstorm 146

In this episode of The Brainstorm, Sam, Nick, and Brett break down Merck and Moderna’s positive Phase 3 results for a personalized mRNA cancer vaccine, a treatment custom-built from each patient’s own...

26 Aug 26min

Anthropic Is The Fastest Growing Software Company Ever | The Brainstorm 145

In this episode of The Brainstorm, Sam and Frank dig into the rumors of a multi-trillion-dollar Anthropic initial public offering (IPO). A company that started the year at $9 billion in run rate reven...

19 Aug 26min

OpenAI's Agents Hacked Their Way Out | The Brainstorm 144

In this episode of The Brainstorm, Sam, Nick, and Brett break down what may be a watershed moment for AI: OpenAI’s agents devised their own secret communication scheme, hacked out of their training sa...

12 Aug 27min

Could China Block A Rumored Tesla-SpaceX Merger? | The Brainstorm 143

In this episode of The Brainstorm, Sam and Nick and Brett discuss whether Tesla’s Shanghai factory could derail a rumored Tesla-SpaceX merger, and why both expect an announcement before the end of the...

7 Aug 29min

Why AI May Need Bitcoin

In this episode of Bitcoin Brainstorm, Rod Roudi is joined by Cathie Wood, Lorenzo Valente, Steve Lee, Jesse Posner, and Paul Itoi to examine the growing convergence of Bitcoin, artificial intelligenc...

6 Aug 1h 13min

The Age Of Free Food Delivery: Manna Air Delivery With Bobby Healy

In this episode of FYI, Tasha Keeney and Daniel Maguire sit down with Bobby Healy, founder and CEO of Manna, to examine the rapidly expanding drone delivery market. Bobby explains how Manna’s autonomo...

30 Jul 50min

SpaceX's Starship Flight 13 + Kimi K3 Freakout | The Brainstorm 142

In this episode of The Brainstorm, Tasha Keeney, Nicholas Grous, and Brett Winton uncover how SpaceX's latest Starship test flight is revolutionizing space travel, slashing launch costs, and how this ...

29 Jul 29min